- Senate passes Drug Quality and Security Act
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- ROUNDTABLE: Pharmacy’s future in sync with technology
- FDA approves Upsher-Smith's Qudexy XR extended-release capsules
- 21 health industry groups address FDA on proposed changes to generic drug label rules
WASHINGTON — The Justice Department late Wednesday reported it will appeal a recent judicial decision that would require removing any age restriction from the purchase of the Plan B emergency contraceptive, according to a report published in USA Today. The decision comes one day after the Food and Drug Administration approved Plan B One Step in females as young as 15 years old and removed merchandising restrictions that mandated the emergency contraceptive be sold from behind the pharmacy counter.
The appeal and the subsequent request for an injunction does not have any bearing on the FDA decision, USA Today reported.
U.S. Attorney Loretta Lynch appealed to the Second Circuit Court to suspend the April 5 district court ruling. District Judge Edward Korman of New York had given FDA until May 5 to lift all age and merchandising restrictions from the sale of Plan B.
Are you a nurse practitioner or physician's assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.